Prestigious Federal Contract Supports Drug Pharmacology Studies at Hillman
Last August, UPMC Hillman Cancer Center became one of only two academic centers in the nation to secure a competitive contract from the National Cancer Institute (NCI) to perform preclinical and...
View ArticleHillman Legacy Lives On at UPMC Hillman Cancer Center
Through Hillman Foundation and Henry L. Hillman Foundation, the late Henry and Elsie Hillman made generous contributions throughout the Pittsburgh region, especially in science and medicine. Their...
View ArticleCombination Targeted Therapy Improves Survival of Stage III Melanoma Patients
It is estimated that 40% of melanomas contain BRAF mutations that promote cancer cell growth. While previous studies have shown that treatment with the combination of inhibitors targeting BRAF...
View ArticleMultispectral Tumor Imaging May Guide Precision Immunotherapy
While novel immunotherapies are revolutionizing the way some cancers are treated, not all patients will respond to treatment, underlining the need for biomarkers that can predict potential clinical...
View ArticleOvarian Cancer Cells Manipulate Surrounding Normal Cells to Aid Tumor Growth
Tumors do not grow in isolation, but are surrounded by a rich microenvironment that contains blood vessels, fibroblasts, immune cells, and a multitude of other components. Cancer cells can influence...
View ArticleHillman Researcher Aims to Target Colorectal Cancer with a Multifaceted Approach
Colorectal cancer (CRC) is a leading cause of cancer death in the United States and worldwide. While common oncogenic mutations in CRC have been identified, attempts to target these pathways have had...
View ArticlePitt and UPMC Launch New Immune Transplant and Therapy Center (ITTC)
On February 13, Pitt and UPMC leaders announced plans to establish the new UPMC Immune Transplant and Therapy Center (ITTC), with much of its activity planned within an eight-story innovation hub—all...
View ArticleClinical Trials at UPMC Hillman Cancer Center
Basic and translational researchers at UPMC Hillman Cancer Center work closely with physician-scientists and clinicians to quickly move the most promising research results from their labs into clinical...
View ArticleHillman Researcher shows that the proapoptotic protein PUMA also enhances...
Multiple classes of chemotherapeutic drugs work by inducing cancer cell death, but these drugs are often ineffective in treating cancer patients. Dr. Lin Zhang, Professor of Pharmacology and Chemical...
View ArticleNew postdoctoral training program at Hillman
We at UPMC Hillman Cancer Center are pleased to announce a new and exciting postdoctoral training opportunity. Made possible by a generous donation from Henry L. Hillman Foundation, the Hillman...
View Article
More Pages to Explore .....